These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8428065)

  • 1. Treatment of acute cerebral infarction.
    Nader J; Bogousslavsky J
    Curr Opin Neurol Neurosurg; 1993 Feb; 6(1):51-4. PubMed ID: 8428065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous tissue plasminogen activator in the treatment of acute ischemic stroke: feasibility, safety, and efficiency in the 2 first years of the clinical practice].
    Feuerhake W; Chamorro H; Araya F
    Rev Med Chil; 1999 Jul; 127(7):814-9. PubMed ID: 10668289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does effect of a neuroprotective agent on volume of experimental animal cerebral infarct predict effect of the agent on clinical outcome in human stroke?
    Jonas S; Tran AQ; Eisenberg E; Azam M; Viera D; Grumet S
    Ann N Y Acad Sci; 1997 Oct; 825():281-7. PubMed ID: 9369994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thrombolytic treatment in acute brain infarction].
    Davalos A
    Neurologia; 2004 May; 19(4):143-5. PubMed ID: 15131732
    [No Abstract]   [Full Text] [Related]  

  • 5. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
    Hill MD; Barber PA; Takahashi J; Demchuk AM; Feasby TE; Buchan AM
    CMAJ; 2000 May; 162(9):1281-4. PubMed ID: 10813008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator for acute ischemic stroke.
    Al-Buhairi AR; Jan MM
    Saudi Med J; 2002 Jan; 23(1):13-9. PubMed ID: 11938357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.
    Bassi S; Albizzati MG; Sbacchi M; Frattola L; Massarotti M
    J Neurosci Res; 1984; 12(2-3):493-8. PubMed ID: 6389896
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized double-blind controlled study of nimodipine in acute cerebral ischemic stroke.
    Nag D; Garg RK; Varma M
    Indian J Physiol Pharmacol; 1998 Oct; 42(4):555-8. PubMed ID: 10874361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for treatment with thrombolysis in an Irish stroke unit.
    Collins DR; O'Neill D; McCormack PM
    Ir Med J; 1999; 92(1):236-8. PubMed ID: 10360096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Cocho D; Belvís R; Martí-Fàbregas J; Molina-Porcel L; Díaz-Manera J; Aleu A; Pagonabarraga J; García-Bargo D; Mauri A; Martí-Vilalta JL
    Neurology; 2005 Feb; 64(4):719-20. PubMed ID: 15728300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous thrombolytic therapy: ideal treatment for acute ischemic stroke].
    Kappelle LJ; van der Worp HB
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1025-8. PubMed ID: 10850102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy of acute ischemic cerebrovascular diseases].
    Gao S; Cui LY
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):137-8. PubMed ID: 15774228
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.
    Jin L; Jin H; Zhang G; Xu G
    Clin Hemorheol Microcirc; 2000; 23(2-4):213-8. PubMed ID: 11321442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
    Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging in acute or subacute stroke: present choices and future possibilities.
    Babikian VL
    J Neuroimaging; 1997 Apr; 7(2):118-9. PubMed ID: 9128452
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of lesion side on acute stroke treatment.
    Di Legge S; Fang J; Saposnik G; Hachinski V
    Neurology; 2005 Jul; 65(1):81-6. PubMed ID: 16009890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differential diagnosis of acute ischemic stroke and management on the basis of acute ischemic stroke subtype].
    Urabe T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):914-7. PubMed ID: 15651330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
    Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
    Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.